Accretion Pharmaceuticals Limited (NSE:ACCPL)

Accretion Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 9, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	1,745	706	-	-	-	-
Enterprise Value	1,828	783	-	-	-	-
Last Close Price	157.00	63.55	-	-	-	-
PE Ratio	17.39	7.31	-	-	-	-
PS Ratio	1.94	0.79	-	-	-	-
PB Ratio	3.19	1.29	-	-	-	-
P/TBV Ratio	3.19	1.29	-	-	-	-
EV/Sales Ratio	2.04	0.87	-	-	-	-
EV/EBITDA Ratio	12.07	5.17	-	-	-	-
EV/EBIT Ratio	13.12	5.62	-	-	-	-
Debt / Equity Ratio	0.23	0.23	0.92	2.45	2.20	2.47
Debt / EBITDA Ratio	0.81	0.81	1.18	5.22	3.96	3.94
Debt / FCF Ratio	-	-	3.41	-	-	4.02
Net Debt / Equity Ratio	0.15	0.15	0.92	2.44	2.19	2.35
Net Debt / EBITDA Ratio	0.55	0.55	1.18	5.19	3.94	3.75
Net Debt / FCF Ratio	-0.36	-0.36	3.40	-0.79	-9.84	3.82
Asset Turnover	1.54	1.54	1.71	0.56	1.54	-
Inventory Turnover	2.66	2.66	2.28	0.85	3.27	-
Quick Ratio	1.27	1.27	0.54	0.46	0.42	0.38
Current Ratio	2.91	2.91	1.44	1.46	1.05	1.01
Return on Equity (ROE)	27.62%	27.62%	65.39%	31.98%	3.00%	-
Return on Assets (ROA)	14.94%	14.94%	20.67%	6.14%	3.96%	-
Return on Invested Capital (ROIC)	16.34%	22.29%	32.12%	11.33%	8.06%	8.26%
Return on Capital Employed (ROCE)	24.90%	24.90%	66.80%	19.00%	18.00%	18.60%
Earnings Yield	5.54%	13.69%	-	-	-	-
FCF Yield	-13.27%	-32.78%	-	-	-	-
Buyback Yield / Dilution	-33.57%	-33.57%	-5.47%	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 10, 2026

Data Sources Report a data error